Analytical Data
-
Gene name
sdrD
- Application
-
Species
Staphylococcus aureus
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O86488
-
Expression Region
36-330aa
-
Molecular Weight
38.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of SDRD (Short-Chain Dehydrogenase/Reductase Domain) recombinant proteins has gained significant attention due to their crucial role in various biochemical processes, including metabolism and cellular signaling. SDRD enzymes are involved in the reduction and oxidation reactions of a wide range of substrates, making them essential for the biosynthesis and degradation of important biological molecules. The versatility of SDRD proteins in catalyzing reactions under different physiological conditions highlights their potential applications in biotechnology and pharmaceuticals. Research has revealed that recombinant SDRD proteins can be engineered to enhance their stability, specificity, and activity, which opens new avenues for therapeutic developments, such as drug design and metabolic engineering. Moreover, understanding the structural and functional characteristics of SDRD proteins can facilitate the discovery of novel enzymes with unique properties, contributing to advancements in synthetic biology. As environmental and health-related challenges continue to rise, the exploration of SDRD recombinant proteins offers promising strategies for addressing these issues through innovative biocatalytic processes.
